Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2006; 12(6): 945-950
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945
Table 1 Characteristics of participating patients
| RegimenAIFN+zinc) | RegimenB (CIFN) | P | |
| Number of entry | 41 | 42 | |
| Male/Female | 28/13 | 21/21 | NS |
| Age (yr) | 60±8.5 | 55±21 | NS |
| Body mass index | 23±2.4 | 24±3.7 | NS |
| Pre-treatment zinc concentration (μg/dl) | 77.8±13.6 | 82.5±16.4 | NS |
| Pre-treatment ALT (IU/l) | 113±75 | 101±96 | NS |
| Pre-treatment leukocyte counts (x103mm-3) | 5.1±1.3 | 5.0±1.4 | NS |
| Pre-treatment platelet counts (x103mm-3) | 19±5 | 17±5 | NS |
| Pre-treatment HCV-RNA genotype (2A/2B) | 31/10 | 31/11 | NS |
| Pre-treatment HCV-RNA titer (KIU/mL) | 484±1075 | 304±318 | NS |
| 0<pretreatment HCV-RNA<100 | 11 | 16 | NS |
| 100 ≤pretreatment HCV-RNA<400 | 15 | 14 | NS |
| 400 ≤pretreatment HCV-RNA<700 | 6 | 2 | NS |
| 700 ≤pretreatment HCV-RNA | 9 | 9 | NS |
| Histological findings (staging) | 1.8±1 | 1.3±0.8 | NS |
| Histological findings (grading) | 1.6±0.7 | 1.3±0.9 | NS |
- Citation: Suzuki H, Sato K, Takagi H, Kanda D, Sohara N, Kakizaki S, Nakajima H, Otsuka T, Nagamine T, Mori M. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol 2006; 12(6): 945-950
- URL: https://www.wjgnet.com/1007-9327/full/v12/i6/945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i6.945